|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 35/17 | (2015.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K 14/725 | (2006.01) |
| (11) | Number of the document | 3845557 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20208043.8 |
| Date of filing the European patent application | 2016-06-12 | |
| (97) | Date of publication of the European application | 2021-07-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201562175003 P | 2015-06-12 | US |
| (72) |
DROPULIC, Boro , US
ORENTAS, Rimas , US
SCHNEIDER, Dina , US
KRUEGER, Winfried , US
|
| (73) |
Lentigen Technology, Inc. ,
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878,
US
|
| (54) | METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |
| METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |